Dose Optimization of Perfusion-derived Response Assessment in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: Comparison of Volume Perfusion CT and Iodine Concentration.
Aged
Aged, 80 and over
Carcinoma, Hepatocellular
/ therapy
Chemoembolization, Therapeutic
/ methods
Cone-Beam Computed Tomography
/ methods
Contrast Media
Female
Humans
Iodine
Liver Neoplasms
/ therapy
Male
Middle Aged
Perfusion Imaging
/ methods
ROC Curve
Regional Blood Flow
Response Evaluation Criteria in Solid Tumors
Retrospective Studies
Contrast media
Hepatocellular carcinoma
Multidetector computed tomography
Perfusion imaging
Therapeutic chemoembolization
Journal
Academic radiology
ISSN: 1878-4046
Titre abrégé: Acad Radiol
Pays: United States
ID NLM: 9440159
Informations de publication
Date de publication:
09 2019
09 2019
Historique:
received:
07
07
2018
revised:
27
09
2018
accepted:
27
09
2018
pubmed:
30
11
2018
medline:
14
5
2020
entrez:
29
11
2018
Statut:
ppublish
Résumé
We assessed the value of iodine concentration (IC) as a perfusion-derived response marker for hepatocellular carcinoma (HCC) treated with transarterial chemoembolization (TACE) in comparison with volume perfusion computed tomography (VPCT) parameters. Forty-one HCC lesions in 32 patients examined before and after TACE were analyzed retrospectively. VPCT-parameters were calculated and lesion iodine-maps were computed using subtraction of the baseline and the scan 7 seconds after aortic peak enhancement from the corresponding 80 kVp-VPCT data set. Modified RECIST was used as standard response criteria. Comparisons were performed using Student's t test for normal distributed data and Mann-Whitney U test for non-normal distributed data. Additionally, correlation analysis, receiver operating characteristics (ROC) and interreader agreement were assessed. In responding lesions, mean pre-TACE IC and blood flow (BF) were 131.2 mg/100 mL and 96.7 mL/100 mL/min, decreasing to IC 25.6 mg/100 mL (P < 0.001) and BF 28.5 mL/100 mL/min (P < 0.001) post-TACE. In nonresponding lesions, the values remained almost unchanged: pre-TACE: mean BF 79.3 mL/100 mL/min and mean IC 90.4 mg/100 mL; post-TACE: mean BF 71.3 mL/100 mL/min (n.s.) and mean IC 105.4 mg/100 mL (n.s.). Differences in IC-values revealed a high sensitivity/specificity of 96.7%/81.8%. IC and VPCT-parameters showed strong, positive correlations. Mean volume CT dose index for VPCT was 63.4 mGy and 4.9 mGy for iodine maps. Thus, IC is a meaningful perfusion marker for local therapy response monitoring in HCC that can be acquired with low radiation dose. This information is important for further therapy response applications using dual and single energy CT.
Identifiants
pubmed: 30482626
pii: S1076-6332(18)30465-3
doi: 10.1016/j.acra.2018.09.026
pii:
doi:
Substances chimiques
Contrast Media
0
Iodine
9679TC07X4
Types de publication
Comparative Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1154-1163Informations de copyright
Copyright © 2018 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved.